
样式: 排序: IF: - GO 导出 标记为已读
-
-
Current Practices and Perspectives on Clerkship Grading in Obstetrics and Gynecology Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-24 Katherine T. CHEN, Laura BAECHER-LIND, Christopher M. MOROSKY, Rashmi BHARGAVA, Angela FLEMING, Celeste S. ROYCE, Jonathan A. SCHAFFIR, Shireen Madani SIMS, Tammy SONN, Alyssa STEPHENSON-FAMY, Jill M. SUTTON, Helen Kang MORGAN
Background Clerkship grades in obstetrics and gynecology play an increasingly important role in the competitive application process to residency programs. An analysis of clerkship grading practices has not been queried in the past two decades in our specialty. Objective To investigate obstetrics and gynecology clerkship directors’ practices and perspectives in grading. Study Design A 12-item electronic
-
Demographic reporting and language exclusion in gynecologic oncology clinical trials Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-24 Sarah S. Lee, Andreea Dinicu, Likolani Arthurs, Danielle Shileds, Bhavana Pothuri, Michelle Ds Lightfoot
Background Participation in clinical trials may help mitigate disparate cancer outcomes. Ensuring equitable access to clinical trials is thus a major priority for national cancer organizations. Objective This study aimed to examine clinical trial eligibility criteria that may adversely impact the enrollment of underrepresented groups and assess the availability of demographic information in published
-
Placental Histology for Targeted Risk Assessment of Recurrent Spontaneous Preterm Birth and Response to 17-alpha hydroxy-progesterone caproate Supplementation Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-24 Sunitha Suresh, Alexa Freedman, Marci Adams, Emmet Hirsch, Linda M. Ernst
Background Spontaneous preterm birth significantly increases the risk for a recurrent preterm birth (rPTB). Few identifiable clinical risk factors exist in counseling of rPTB. Furthermore, treatment with progesterone supplementation has not consistently prevented preterm birth in high-risk patients, but may be effective in a subset of such patients. Placental pathology from a prior pregnancy may be
-
AJOG MFM Table of Contents Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-25
Abstract not available
-
AJOG GR Table of Contents Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-25
Abstract not available
-
-
Desirability Of Outcome Ranking (DOOR) for Obstetric Trials: Illustration and Application to the ARRIVE Trial Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-22 Grecio J. SANDOVAL, William A. GROBMAN, Scott R. EVANS, Madeline M. RICE, Rebecca G. CLIFTON, Suneet P. CHAUHAN, Maged M. COSTANTINE, Kelly S. GIBSON, Monica LONGO, Torri D. METZ, Emily S. MILLER, Samuel PARRY, Uma M. REDDY, Dwight J. ROUSE, Hyagriv N. SIMHAN, John M. THORP, Alan T.N. TITA, George R. SAADE,
Background In randomized trials, one primary outcome is typically chosen to evaluate the consequences of an intervention while other important outcomes are relegated to secondary outcomes. This issue is amplified for many obstetric trials in which an intervention may have consequences for both the pregnant person and the child. In contrast, desirability of outcome ranking (DOOR), a paradigm shift for
-
The Hard Palate Sweep: a multiplanar 2D sonographic method for the prenatal detection of cleft palate Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-21 Tal WEISSBACH, Shir LEV, Adina HAIMOV, Abeer MASSARWA, Idan SHAMAY, Roni PLASCHKES, Lior ASSA, Tal ELKAN-MILLER, Boaz WEISZ, Gil NARDINI, Noam ARMON, Roni SHARON, Shali MAZAKI TOVI, Eran KASSIF
Background Prenatal diagnosis of cleft palate is challenging. Numerous 2D and 3D methods have been proposed to assess the integrity of the fetal palate, yet detection rate remains relatively low. We propose the "Hard Palate Sweep", a novel 2D method which enables a clear demonstration of the entire fetal palate throughout pregnancy, in a single sweep, avoiding acoustic shadows cast by surrounding bones
-
Third trimester fetoscopic ablation therapy for types II and III vasa previa Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-21 Ramen H. CHMAIT, Martha A. MONSON, Andrew H. CHON, Ms. Jinnen MASRI, Lisa M. KORST, Marc H. INCERPI
Background Vasa previa is an obstetrical condition in which fetal vessels traverse the fetal membranes unprotected by underlying placenta and located near the cervix. Type I vasa previa arises directly from a velamentous cord root, while types II and III arise from an accessory lobe or a distal lobe of the same placenta, respectively. Fetoscopic laser ablation for types II and III vasa previa is a
-
Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-19 Alan H. JOBE, Robert L. GOLDENBERG, Matthew W. KEMP
Antenatal steroid therapy is increasingly central to the obstetric management of women at imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks’ gestation, antenatal steroid therapy is standard of care, conveying sizable benefits and few risks in high-resource environments when appropriately targeted. Recent studies have focused on antenatal steroid use in periviable and
-
The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors—a prospective cohort study of 240,000 women in the UK Biobank Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-19 Valeria Lo Faro, Therese Johansson, Åsa Johansson
Background Over 150 million women worldwide use oral contraceptives. Women with inherited thrombophilia and carriers of certain thrombophilia gene variants, such as factor V Leiden and prothrombin mutation, are at increased risk of venous thromboembolism, especially in combination with oral contraceptive use. Venous thromboembolism is a complex disorder involving many genetic risk factors and recently
-
Term neonatal brain MRI after acidosis in cord blood Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Floris Groenendaal
Abstract not available
-
High BMI pregnancies require serial assessment of fetal size and growth velocity Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Jason Gardosi, Oliver Hugh
Abstract not available
-
Peripartum extracorporeal cardiopulmonary resuscitation and rescue aspiration pulmonary embolectomy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Marta V. Antonini, Alessandro Circelli, Fabio F. Tarantino, Luca Bissoni, Rita Pini, Patrizio GM. Antonazzo, Vanni Agnoletti
Abstract not available
-
Prenatal versus Postnatal Diagnosis of 22q11.2 Deletion Syndrome: Cardiac and Non-Cardiac Outcomes through 1 Year of Age Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Lindsay R. Freud, Stephanie Galloway, T. Blaine Crowley, Julie Moldenhauer, Ann Swillen, Jeroen Breckpot, Antoni Borrell, Neeta L. Vora, Bettina Cuneo, Hilary Hoffman, Lisa Gilbert, Beata Nowakowska, Maciej Geremek, Anna Kutkowska-Kaźmierczak, Joris R. Vermeesch, Koen Devriendt, Tiffany Busa, Sabine Sigaudy, Trisha Vigneswaran, John M. Simpson, Donna M. McDonald-McGinn
Background 22q11.2 deletion syndrome (22qDS) is the most common microdeletion syndrome and is frequently associated with congenital heart disease (CHD). Prenatal diagnosis of 22qDS is increasingly offered. It is unknown whether there is a clinical benefit to prenatal detection as compared to postnatal diagnosis. Objective To determine differences in perinatal and infant outcomes between patients prenatally
-
In obese mothers fetal growth decline may reflect placental dysfunction and high stillbirth risk Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Carbillon L
Abstract not available
-
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-16 Touria Hajri, Mona Massoud, Margot Vergne, Pierre Descargues, Fabienne Allias, Benoit You, Jean-Pierre Lotz, Julie Haesebaert, Pierre-Adrien Bolze, François Golfier, Jerome Massardier
BACKGROUND Multiple pregnancy with a complete hydatidiform mole and a normal fetus is prone to severe obstetrical complications and malignant transformation after birth. Prognostic information is limited for this rare form of gestational trophoblastic disease. OBJECTIVE This study aimed to determine obstetrical outcomes and the risk of gestational trophoblastic neoplasia in women with multiple pregnancy
-
Intrauterine manipulator during hysterectomy for endometrial cancer: a systematic review and meta-analysis of oncologic outcomes. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-12 Pier Carlo ZORZATO, Stefano UCCELLA, Giulia BIANCOTTO, Mariachiara BOSCO, Anna FESTI, Massimo FRANCHI, Simone GARZON
Objective To assess the effects on oncological outcomes of intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer. Data sources A systematic literature search was performed by an expert librarian in multiple electronic databases from inception to January 31, 2023. Study eligibility criteria We included all studies in the English language that compared oncologic outcomes
-
Postmenopausal bleeding after COVID-19 vaccination Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-17 Tia L. KAUFFMAN, Stephanie A. IRVING, Neon BROOKS, Kimberly K. VESCO, Matthew SLAUGHTER, Ning SMITH, Naomi K. TEPPER, Christine K. OLSON, Eric S. WEINTRAUB, Allison L. NALEWAY
Background There is a growing literature base regarding menstrual changes following COVID-19 vaccination among premenopausal people. However, relatively little is known about uterine bleeding in postmenopausal people following COVID-19 vaccination. Objectives To examine trends in incident postmenopausal bleeding diagnoses over time before and after COVID-19 vaccine introduction and describe cases of
-
Accelerated epigenetic clock aging in maternal peripheral blood and preterm birth Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-09 Emily L. GASCOIGNE, Kyle R. ROELL, Lauren A. EAVES, Rebecca C. FRY, Tracy A. MANUCK
BACKGROUND Epigenetic clocks use CpG DNA methylation (DNAm) to estimate biologic age; acceleration is associated with cancer, heart disease, and shorter lifespan. Few studies evaluate DNAm age and pregnancy outcomes. AgeAccelGrim is a novel epigenetic clock that combines seven DNAm components. OBJECTIVES We sought to determine if maternal biologic aging (via AgeAccelGrim) is associated with early PTB
-
Testosterone Use and Sexual Function among Transgender Men and Gender Diverse People Assigned Female at Birth Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-09 Diana M. TORDOFF, Mitchell R. LUNN, Bertha CHEN, Annesa FLENTJE, Zubin DASTUR, Micah E. LUBENSKY, Matthew CAPRIOTTI, Juno OBEDIN-MALIVER
Background Testosterone use among transgender people likely impacts their experience of sexual function and vulvovaginal pain via several complex pathways. Testosterone use is associated with decreased estrogen in the vagina and atrophic vaginal tissue, which may be associated with decreased vaginal lubrication and/or discomfort during sexual activity. At the same time, increased gender affirmation
-
Practice patterns and complications of hysterectomy for invasive cervical cancer after the LACC trial. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-09 Gabriella SCHIVARDI, Jvan CASARIN, Elizabeth B. HABERMANN, Katherine A. BEWS, Carrie LANGSTRAAT, William CLIBY, Giuseppe CUCINELLA, Luigi A. DE VITIS, Pedro T. RAMIREZ, Giovanni D. ALETTI, Andrea MARIANI, Francesco MULTINU
Background After the publication of the LACC trial, the standard surgical approach for early-stage cervical cancer is open radical hysterectomy. Only limited data were available regarding whether the change to open abdominal hysterectomy observed after the LACC trial led to an increase in post-operative complication rates as a consequence of the decrease in use of the minimally invasive approach. Objective
-
Society for Maternal-Fetal Medicine Special Statement: Emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-09 , Brett D. EINERSON, Andrew J. HEALY, Amy LEE, Christine WARRICK, C. Andrew COMBS, Afshan B. HAMEED
Placenta accreta spectrum is a dangerous complication of pregnancy that is underdiagnosed and can result in massive hemorrhage, disseminated intravascular coagulation, massive transfusion, surgical injury, multisystem organ failure, and even death. Given the rarity and complexity, most obstetric hospitals and providers do not have comprehensive expertise in diagnosis and management of placenta accreta
-
Operative delivery in the second stage of labour and preterm birth in a subsequent pregnancy: a systematic review and meta-analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-04 Abirami Kirubarajan, Nila Thangavelu, Misgav Rottenstreich, Giulia M. MURACA
Objective To quantify the association between mode of operative delivery in the second stage of labour (cesarean delivery versus operative vaginal delivery) and spontaneous preterm birth (sPTB) in a subsequent pregnancy. Data Sources MEDLINE, EMBASE, Emcare, CINAHL, the Cochrane Library, Web of Science: Core Collection, and Scopus from database inception to April 1st 2023 Study eligibility criteria
-
LIBERTY Randomized Withdrawal Study: Relugolix Combination Therapy for Heavy Menstrual Bleeding Associated With Uterine Fibroids Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-02 Ayman AL-HENDY, Roberta VENTURELLA, Juan Camilo ARJONA FERREIRA, Yulan Li, Graziella SOULBAN, Rachel B. WAGMAN, Andrea S. LUKES
Background In the pivotal LIBERTY 1 and 2 trials and long-term extension (LTE) study, once-daily relugolix combination therapy (relugolix CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) reduced menstrual blood loss (MBL) volume and pain in women with uterine fibroids (UF). Relugolix CT was well tolerated, with preservation of bone mineral density (BMD) through 52 weeks. Objective
-
Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: A case series Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-02 Murat SÖNMEZER, Yavuz Emre ŞÜKÜR, Koray Görkem SAÇINTI, Sinan ÖZKAVUKÇU, Duygu KANKAYA, Cem Somer ATABEKOĞLU, Güldane CENGİZ SEVAL, Kutluk H. OKTAY
Background With increased success, ovarian tissue cryopreservation has recently become a standard technique for fertility preservation. However, malignant cell introduction through ovarian tissue transplantation remains a major concern for patients with acute leukemias. Objective To investigate the safety of performing autologous ovarian tissue transplantation in acute leukemia survivors. Study Design
-
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: Response Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-01 Xia Wei, Samuel Oxley, Michail Sideris, Rosa Legood, Ranjit Manchanda
Abstract not available
-
Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast/ovarian cancer Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-01 Junyi Zhou, Pengfei Wu, Yangyang Zhang
Abstract not available
-
Association between stillbirth and severe maternal morbidity Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-09-01 Samuel H. Nyarko, Lucy T. Greenberg, Ciaran S. Phibbs, Jeffrey S. Buzas, Scott A. Lorch, Jeannette Rogowski, George R. Saade, Molly Passarella, Nansi S. Boghossian
Background Severe maternal morbidity (SMM) has been increasing in the past few decades. Few studies have examined the risk of SMM among individuals experiencing a stillbirth versus a live birth. Objective To examine the prevalence and risk of SMM among individuals with stillbirth versus individuals with live birth deliveries during delivery hospitalization as a primary outcome and during postpartum
-
Intrauterine devices in the management of postpartum hemorrhage Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-30 Eve Overton, Mary D’Alton, Dena Goffman
Obstetrical hemorrhage is a relatively frequent obstetric complication, and a common cause of maternal morbidity and mortality worldwide. The majority of maternal deaths attributable to hemorrhage are preventable, thus developing rapid and effective means of treating postpartum hemorrhage is of critical public health importance. Uterine balloon tamponade is one option for management of refractory postpartum
-
Cost-effectiveness of history-indicated cerclage versus cervical length assessment for prevention of preterm birth: a comment. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-26 Yoann Athiel, Aude Girault, François Goffinet
Abstract not available
-
Evidence regarding the management of patients with prior preterm birth limits any economic analysis. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-26 Lea NEHME, George SAADE, Tetsuya KAWAKITA
Abstract not available
-
The Application of Transient Elastography for Early Diagnosis of Pregnancy-Related Complications Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-25 Khawaja Hassam, Muhammad Asad Raza, Mati Ullah Dad Ullah
Abstract not available
-
GESTATIONAL HYPERTENSION: TIME FOR A NEW NAME? Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-25 Yinka Oyelese
Abstract not available
-
Pre-eclampsia or non-alcoholic fatty liver disease: is it only overlap which explains increased liver stiffness, observed in ante- and post-partum elastography? Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-25 Michal Carmiel Haggai
Abstract not available
-
Abortion training information on obstetrics and gynecology residency program websites Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-25 Bektu Solomon, Meredith J. Alston, Christine Conageski, Jeanelle L. Sheeder, Rebecca H. Cohen
Abstract not available
-
-
Information for readers Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24
Abstract not available
-
AJOG MFM Table of Contents Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24
Abstract not available
-
AJOG GR Table of Contents Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24
Abstract not available
-
-
The ethics of induction of labor at 39 weeks in low-risk nulliparas in research and clinical practice Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24 Elie Azria, Thibaud Haaser, Thomas Schmitz, Alizée Froeliger, Hanane Bouchghoul, Hugo Madar, Beth L. Pineles, Loïc Sentilhes
The “A Randomized Trial of Induction Versus Expectant Management” trial (ARRIVE trial) published in 2018 suggested that induction of labor can be considered a “reasonable option” for low-risk nulliparous women at ≥39 weeks of gestation. The study results led some professional societies to endorse the option for elective induction of labor at 39 weeks of gestation in low-risk nulliparas, and this has
-
The Persistency Index: a novel screening tool for identifying myofascial pelvic floor dysfunction in patients seeking care for lower urinary tract symptoms Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24 A. Lenore Ackerman, Michele Torosis, Nicholas J. Jackson, Ashley T. Caron, Melissa R. Kaufman, Jerry L. Lowder, Jonathan C. Routh
Background Patients with myofascial pelvic floor dysfunction often present with lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, and bladder pressure. Often confused with other lower urinary tract disorders, this constellation of symptoms, recently termed myofascial urinary frequency syndrome (MUFS), is distinct from other LUTS and optimally responds to pelvic floor physical
-
Closed- or open-glottis pushing for vaginal delivery: a planned secondary analysis of the TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery study Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24 Alizée Froeliger, Catherine Deneux-Tharaux, Hugo Madar, Hanane Bouchghoul, Camille Le Ray, Loïc Sentilhes
Background The effect on obstetrical outcomes of closed- or open-glottis pushing is uncertain among both nulliparous and parous women. Objective This study aimed to assess the association between open- or closed-glottis pushing and mode of delivery after an attempted singleton vaginal birth at or near term. Study Design This was an ancillary planned cohort study of the TRAAP (TRAnexamic Acid for Preventing
-
Mohs surgery for female genital Paget’s disease: A prospective observational trial Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-24 Kelly H. Bruce, Toni P. Kilts, Mary E. Lohman, Nahid Y. Vidal, Angela J. Fought, Michaela E. McGree, Gary L. Keeney, Christian L. Baum, Jerry D. Brewer, Jamie N. Bakkum-Gamez, William A. Cliby
Background Extramammary Paget’s disease recurs often after traditional surgical excision. Margin-controlled surgery improves recurrence rate for male genital disease but is less studied for female anatomy. Objective To compare surgical and oncologic outcomes of margin-controlled vs traditional surgical excision for female genital Paget’s disease. Study Design We conducted a prospective observational
-
A new technique to preserve the uterus in patients with placenta accreta spectrum disorders Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-23 Sergey V. Barinov, Gian Carlo Di Renzo
Background Placenta accreta spectrum disorders are associated with substantial maternal morbidity and mortality. Despite a preoperative diagnosis, the rate of complications remains high and the condition is generally associated with the need for a hysterectomy. Objective To evaluate the outcomes of a new uterine-preserving technique (called the combined approach, including surgical hemostasis, bilateral
-
Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-23 Wolfgang Henrich, Anna Dückelmann, Thorsten Braun, Larry Hinkson
Postpartum hemorrhage remains a major cause of maternal mortality and morbidity worldwide with higher rates found in resource-challenged countries. Conventional use of uterotonics such as oxytocin, prostaglandins, and medications to support coagulation, such as fibrinogen and tranexamic acid, are helpful but may not be sufficient to arrest life-threatening postpartum hemorrhage. Severe postpartum hemorrhage
-
Uterine-sparing surgical procedures to control postpartum hemorrhage Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-23 Hanane Bouchghoul, Hugo Madar, Benoit Resch, Beth L. Pineles, Aurélien Mattuizzi, Alizée Froeliger, Loïc Sentilhes
Postpartum hemorrhage remains one of the principal causes of maternal mortality in the United States and throughout the world. Its management, which must be multidisciplinary (obstetrics, midwifery, anesthesiology, interventional radiology, and nursing), depends on the speed of both diagnosis and implementation of medical and surgical treatment to control the hemorrhage. The aim of this work is to
-
The role of viscoelastic hemostatic assays for postpartum hemorrhage management and bedside intrapartum care Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-23 Daniel Katz, Michaela Farber, Chloe Getrajdman, Joshua Hamburger, Sharon Reale, Alexander Butwick
Viscoelastic hemostatic assays are point-of-care devices that assess coagulation and fibrinolysis in whole blood samples. These technologies provide numeric and visual information of clot initiation, clot strength, and clot lysis under low-shear conditions, and have been used in a variety of clinical settings and subpopulations, including trauma, cardiac surgery, and obstetrics. Emerging data indicate
-
Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-21 Alyssa R. Hersh, Guillermo Carroli, G. Justus Hofmeyr, Bharti Garg, Metin Gülmezoglu, Pisake Lumbiganon, Bremen De Mucio, Sarah Saleem, Mario Philip R. Festin, Suneeta Mittal, Jorge Andres Rubio-Romero, Tsungai Chipato, Catalina Valencia, Jorge E. Tolosa
The third stage of labor is defined as the time period between delivery of the fetus through delivery of the placenta. During a normal third stage, uterine contractions lead to separation and expulsion of the placenta from the uterus. Postpartum hemorrhage is a relatively common complication of the third stage of labor. Strategies have been studied to mitigate the risk of postpartum hemorrhage, leading
-
Changes in numbers and academic ranks of Hispanic faculty in departments of obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-20 Imam M. Xierali, Iris L. Romero, William F. Rayburn
Abstract not available
-
Patient au-T-onomy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-21 Alexander M. Quaas
Abstract not available
-
Pre-pregnancy plant-based diets and risk of hypertensive disorders of pregnancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-19 Makiko MITSUNAMI, Siwen WANG, Diana C. SORIA-CONTRERAS, Lidia MINGUEZ-ALARCON, Eduardo ORTIZ-PANOZO, Jennifer J. STUART, Irene SOUTER, Janet W. RICH-EDWARDS, Jorge E. CHAVARRO
Background Plant-based diets (PBD) have been associated to a lower risk of cardiovascular disease in non-pregnant adults, but specific evidence for their effects on risk of hypertensive disorders of pregnancy (HDP) is scarce. Objective(s) To evaluate the prospective association between adherence to PBD before pregnancy and risk of HDP. We hypothesized that women with higher adherence to PBD would have
-
Zika virus co-opts miRNA networks to persist in placental niches detected by spatial transcriptomics Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-19 Enrico R. Barrozo, Maxim D. Seferovic, Mark P. Hamilton, David N. Moorshead, Michael D. Jochum, Trang Do, Derek S. O’Neil, Melissa A. Suter, Kjersti M. Aagaard
BACKGROUND Zika virus (ZIKV) congenital infection evades double-stranded RNA detection and may persist in the placenta for the duration of pregnancy, without accompanying overt histopathologic inflammation. Understanding how viruses can persist and replicate in the placenta, without causing overt cellular or tissue damage, is fundamental to deciphering mechanisms of maternal-fetal vertical transmission
-
Association of genital talc and douche use in early adolescence or adulthood with uterine fibroids diagnoses Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-18 Kemi Ogunsina, Dale P. Sandler, John D. Murphy, Quaker E. Harmon, Aimee A. D’aloisio, Donna D. Baird, Katie M. O’brien
BACKGROUND Genital talc and douching are practices that can involve exposure to chemical compounds linked to certain gynecologic cancers. However, it is unclear if they are associated with fibroid risk or age at fibroid diagnosis among women. OBJECTIVE We evaluated the impact of early adolescence genital talc use and douching on prevalent fibroids diagnosed before age 35 and age 50 years among Black/African
-
Risk of spontaneous preterm birth elevated after first caesarean section at full dilatation: a retrospective cohort study of over 30,000 women Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-18 Andrea M. Woolner, Edwin-Amalraj Raja, Sohinee Bhattacharya, Mairead E. Black
Background Having a Caesarean section at full dilatation (CSfd) has been associated with an increased subsequent risk of spontaneous preterm birth (sPTB). The Aberdeen Maternity and Neonatal Databank (AMND) provides a rare opportunity to study subsequent pregnancy outcomes after a previous CSfd over 40 years with an ability to include a detailed evaluation of potential confounding factors. Objective(s)
-
Gestational diabetes mellitus and adverse maternal and perinatal outcomes in twin and singleton pregnancies: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-17 Elena GRECO, Maria CALANDUCCI, Kypros H. NICOLAIDES, Eleanor VH. BARRY, Mohammed SB. HUDA, Stamatina ILIODROMITI
Objective To assess the risk of adverse maternal and perinatal complications in twin and singleton pregnancies affected by gestational diabetes mellitus (GDM), compared to the respective group without GDM. Data sources Medline, Embase and Cochrane (January 1980 to May 2023). Study eligibility criteria Observational studies reporting maternal and perinatal outcomes in singletons and/or twin pregnancies
-
A critical evaluation of the external and internal maneuvers for resolution of shoulder dystocia Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-17 So Ling Lau, Wing To Angela Sin, Lo Wong, Nikki May Wing Lee, Shuk Yi Annie Hui, Tak Yeung Leung
In the management of shoulder dystocia, it is often recommended to start with external maneuvers, such as the McRoberts maneuver and suprapubic pressure, followed by internal maneuvers including rotation and posterior arm delivery. However, this sequence is not based on scientific evidence of its success rates, the technical simplicity, or the related complication rates. Hence, this review critically
-
CLINICAL COURSE OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 A POPULATION-BASED COHORT STUDY Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2023-08-16 Kathrine D. LYCKE, Johnny KAHLERT, Rikke K. DAMGAARD, Dina O. ERIKSEN, Mary H. BENNETSEN, Patti E. GRAVITT, Lone K. PETERSEN, Anne HAMMER
Background Cervical intraepithelial neoplasia grade 2 has historically been the threshold for surgical excision, but due to high regression rates, many countries are transitioning to active surveillance. Yet, estimates for regression rates are based on small studies with heterogenous definitions of regression and progression. Objectives The aim of this study was to describe regression and progression